Latest news for CoBank (OTC:CKNQP) Stock

CoBank

CoBank ACB

CoBank ACB is engaged in providing cooperative banking services. It provides loans, leases, export financing, and other financial services to agribusinesses and rural power, water, and communications providers. The firm provides a broad range of loans and other financial services through three operating segments: Agribusiness, Farm Credit Banking and Rural Infrastructure. The firm generates majority of the revenue from Agribusiness segment.

<p>The earnings results for <strong>StealthGas</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GASS#NASDAQ">GASS</a>) for Q3 were made public on Monday, November 25, 2024 at 09:10 AM.</p>
<p>Here's a comprehensive overview of the announcement.</p>
<h3>Earnings</h3>
<p>StealthGas beat estimated earnings by 15.0%, reporting an EPS of $0.38 versus an estimate of $0.33.</p>
<p>Revenue was up $5.79 million from the same period last year.</p>
<h3>Overview of Past Earnings</h3>
<p>The company beat on EPS by $0.22 in the last quarter, resulting in a 2.0% drop share price change the following day.</p>
<p>Here's a look at StealthGas's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.53</td>
<td>0.24</td>
<td>0.30</td>
<td>0.15</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.75</td>
<td>0.53</td>
<td>0.29</td>
<td>0.16</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>39.20M</td>
<td>34.30M</td>
<td>33.90M</td>
<td>27.50M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>41.79M</td>
<td>41.56M</td>
<td>34.14M</td>
<td>34.65M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for StealthGas <a href="https://www.benzinga.com/quote/GASS/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Earnings

GASS

StealthGas Q3 Earnings Assessment

<p><strong>Fluence Energy</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNC#NASDAQ">FLNC</a>) reported its Q4 earnings results on Monday, November 25, 2024 at 04:26 PM.</p>
<p>Here's what investors need to know about the announcement.</p>
<h3>Earnings</h3>
<p>Fluence Energy beat estimated earnings by 13.0%, reporting an EPS of $0.34 versus an estimate of $0.3.</p>
<p>Revenue was up $555.02 million from the same period last year.</p>
<h3>Previous Earnings Records</h3>
<p>The company beat on EPS by $0.11 in the last quarter, resulting in a 15.0% increase share price change the following day.</p>
<p>Here's a look at Fluence Energy's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.11</td>
<td>-0.07</td>
<td>-0.13</td>
<td>-0.06</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0</td>
<td>-0.07</td>
<td>-0.14</td>
<td>0.02</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>455.51M</td>
<td>578.76M</td>
<td>407.61M</td>
<td>515.67M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>328.09M</td>
<td>623.14M</td>
<td>363.96M</td>
<td>672.98M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Fluence Energy <a href="https://www.benzinga.com/quote/FLNC/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


FLNC

Fluence Energy Earnings Review: Q4 Summary

News

Asset Sales

Spruce Power Holding Corporation Class A Common Stock

SPRU

NJR Clean Energy Ventures Announces The Sale Of Its Residential Solar Portfolio To Spruce Power Holding For $132.5M

<p>Fluence Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNC#NASDAQ">FLNC</a>) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.31 by 9.68 percent. This is a 1600 percent increase over earnings of $0.02 per share from the same period last year.  The company reported quarterly sales of $1.23 billion which missed the analyst consensus estimate of $1.30 billion by 5.61 percent.  This is a 82.47 percent increase over sales of $672.98 million the same period last year.</p>


Earnings Beats

Earnings Misses

Fluence Energy Q4 2024 GAAP EPS $0.34 Beats $0.31 Estimate, Sales $1.23B Miss $1.30B Estimate

WIIM

SANW

S&W Seed shares are trading higher after the company announced it has finalized the voluntary plan of administration  process for its subsidiary, S&W Seed Company Australia.

<p>BBB Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TBBB#NYSE">TBBB</a>) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.03 by 233.33 percent.  The company reported quarterly sales of $784.20 million which beat the analyst consensus estimate of $776.51 million by 0.99 percent.</p>


TBBB

BBB Foods Q3 EPS $0.10 Beats $0.03 Estimate, Sales $784.20M Beat $776.51M Estimate

<p>As previously reported, S&amp;W Australia adopted a voluntary administration process on July 24, 2024, and on October 11, 2024 creditors of S&amp;W Australia approved a proposed Deed of Company Arrangement pursuant to which, among other things, 100% of the shares in S&amp;W Australia would be transferred to Avior Asset Management No. 3 Pty Ltd. The effective date of the DOCA is November 22, 2024.&nbsp;</p>


S&W Seed Finalizes Voluntary Plan Of Administration Process For Subsidiary S&W Australia; On November 22, S&W Entered Settlement Agreement In Exchange For Release From Intercompany Obligations Owed To S&W Australia

SMTC

Semtech shares are trading higher after the company reported better-than-expected Q3 adjusted EPS and sales, and provided Q4 EPS and revenue guidance above analyst estimates.

Semtech shares are trading higher after the company reported better-than-expected Q3 financial results and issued Q4 guidance with its midpoint above estimates.

<p>Astronics Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATRO#NASDAQ">ATRO</a>) ("Astronics" or the "Company") today announced that it intends to offer, subject to market and other conditions, $150 million aggregate principal amount of convertible senior notes due 2030 (the "Notes") in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Astronics also expects to grant to the initial purchasers of the Notes an option to purchase up to an additional $15 million aggregate principal amount of the Notes, for settlement within a 13-day period beginning on, and including, the first date on which the Notes are issued.</p>


Offerings

ATRO

Astronics Corporation Announces $150M Convertible Senior Notes Due 2030 Offering

LESL

Leslie's shares are trading lower after the company reported worse-than-expected Q4 adjusted EPS and sales.

CLRO

ClearOne shares are trading higher after the company announced it has engaged ARC Group to explore strategic alternatives, including a merger, sale, or spin-off, to maximize shareholder value. Additionally, board member Larry Hendricks will not seek re-election in 2024.

<p>The Q4 earnings report for <strong>Leslies</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LESL#NASDAQ">LESL</a>) was released on Monday, November 25, 2024 at 04:05 PM.</p>
<p>Here's what investors need to know about the latest announcement.</p>
<h3>Earnings</h3>
<p>Leslies missed estimated earnings by -82.0%, reporting an EPS of $0.02 versus an estimate of $0.11.</p>
<p>Revenue was down $34.51 million from the same period last year.</p>
<h3>Performance in Previous Earnings</h3>
<p>In the previous quarter, the company missed on EPS by $0.08, resulting in a 14.000000000000002% increase change in the share price the following day.</p>
<p>Here's a look at Leslies's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.42</td>
<td>-0.18</td>
<td>-0.21</td>
<td>0.18</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.34</td>
<td>-0.17</td>
<td>-0.20</td>
<td>0.14</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>615.41M</td>
<td>200.92M</td>
<td>169.61M</td>
<td>419.39M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>569.64M</td>
<td>188.66M</td>
<td>173.96M</td>
<td>432.37M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Leslies <a href="https://www.benzinga.com/quote/LESL/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Leslies Earnings Report: Q4 Overview

Guidance

Leslies Sees Q1 2025 Revenue $169M-$176M Vs $178.41M Estimate; Sees Adj. EPS $(0.21)-$(0.20) Vs $(0.19) Estimate

<p>The Q3 earnings report for <strong>Semtech</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTC#NASDAQ">SMTC</a>) was released on Monday, November 25, 2024 at 04:15 PM.</p>
<p>Here's what investors need to know about the latest announcement.</p>
<h3>Earnings</h3>
<p>Semtech beat estimated earnings by 13.0%, reporting an EPS of $0.26 versus an estimate of $0.23.</p>
<p>Revenue was up $35.90 million from the same period last year.</p>
<h3>Performance in Previous Earnings</h3>
<p>Last quarter the company beat on EPS by $0.02 which was followed by a 11.0% increase in the share price the next day.</p>
<p>Here's a look at Semtech's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2025</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.09</td>
<td>0.11</td>
<td>-0.03</td>
<td>-0.13</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.11</td>
<td>0.06</td>
<td>-0.06</td>
<td>0.02</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>212.30M</td>
<td>210.16M</td>
<td>196.46M</td>
<td>204.49M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>215.35M</td>
<td>206.10M</td>
<td>192.95M</td>
<td>200.90M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Semtech <a href="https://www.benzinga.com/quote/SMTC/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Semtech: Q3 Earnings Insights

<p>Baird  analyst Tristan Gerra   initiates coverage on Rambus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NASDAQ">RMBS</a>) with a Outperform rating and announces Price Target of $90.</p>


Price Target

Initiation

Analyst Ratings

RMBS

Baird Initiates Coverage On Rambus with Outperform Rating, Announces Price Target of $90

<p>BioHarvest Sciences Inc. - Common Stock (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BHST#NASDAQ">BHST</a>) reported quarterly losses of $(0.16) per share. This is a 23.08 percent decrease over losses of $(0.13) per share from the same period last year.  The company reported $6.54 million in sales this quarter. This is a 101.88 percent increase over sales of $3.24 million the same period last year.</p>


BHST

BioHarvest Sciences Inc. - Common Stock Q3 EPS $(0.16) Down From $(0.13) YoY, Sales $6.54M Up From $3.24M YoY

<p>Baird  analyst Joel Beatty   initiates coverage on Bright Minds Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRUG#NASDAQ">DRUG</a>) with a Outperform rating and announces Price Target of $75.</p>


DRUG

Baird Initiates Coverage On Bright Minds Biosciences with Outperform Rating, Announces Price Target of $75

<p><strong>Central Garden &amp; Pet</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENT#NASDAQ">CENT</a>) announced its Q4 earnings on Monday, November 25, 2024 at 04:02 PM.</p>
<p>Here's a breakdown of the earnings report.</p>
<h3>Earnings</h3>
<p>Central Garden &amp; Pet beat estimated earnings by 10.0%, reporting an EPS of $-0.18 versus an estimate of $-0.2.</p>
<p>Revenue was down $80.66 million from the same period last year.</p>
<h3>Overview of Past Earnings</h3>
<p>Last quarter the company beat on EPS by $0.11 which was followed by a 6.0% increase in the share price the next day.</p>
<p>Here's a look at Central Garden &amp; Pet's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.21</td>
<td>0.80</td>
<td>-0.14</td>
<td>0.06</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.32</td>
<td>0.99</td>
<td>0.01</td>
<td>0.08</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>1.00B</td>
<td>887.42M</td>
<td>619.95M</td>
<td>735.32M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>996.35M</td>
<td>900.09M</td>
<td>634.53M</td>
<td>750.15M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Central Garden &amp; Pet <a href="https://www.benzinga.com/quote/CENT/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


CENT

Recap: Central Garden & Pet Q4 Earnings

<p><strong>Central Garden &amp; Pet</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENTA#NASDAQ">CENTA</a>) just disclosed its Q4 earnings on Monday, November 25, 2024 at 04:02 PM.</p>
<p>Here's a brief overview of the earnings report.</p>
<h3>Earnings</h3>
<p>Central Garden &amp; Pet beat estimated earnings by 18.0%, reporting an EPS of $-0.18 versus an estimate of $-0.22.</p>
<p>Revenue was down $80.66 million from the same period last year.</p>
<h3>Previous Earnings Records</h3>
<p>The company beat on EPS by $0.02 in the last quarter, resulting in a 0.0% increase share price change the following day.</p>
<p>Here's a look at Central Garden &amp; Pet's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.20</td>
<td>1.21</td>
<td>0.80</td>
<td>0.76</td>
<td>-0.14</td>
<td>-0.14</td>
<td>0.06</td>
<td>0.06</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.32</td>
<td>1.32</td>
<td>0.99</td>
<td>0.99</td>
<td>0.01</td>
<td>0.01</td>
<td>0.08</td>
<td>0.08</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>1.00B</td>
<td>1.00B</td>
<td>887.42M</td>
<td>883.42M</td>
<td>619.95M</td>
<td>619.95M</td>
<td>735.32M</td>
<td>735.32M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>996.35M</td>
<td>996.35M</td>
<td>900.09M</td>
<td>900.09M</td>
<td>634.53M</td>
<td>634.53M</td>
<td>750.15M</td>
<td>750.15M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Central Garden &amp; Pet <a href="https://www.benzinga.com/quote/CENTA/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Comments

CoBank

News

Latest news for CoBank (OTC:CKNQP) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga